Search Results - "Lux, MP"

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer by Michailidou, Kyriaki, Lu, Yingchang, Cai, Qiuyin, Rozali, Esdy, Li, Bingshan, Barfield, Richard T., Andrulis, Irene L., Anton-Culver, Hoda, Barrdahl, Myrto, Baynes, Caroline, Beckmann, Matthias W., Benitez, Javier, Brauch, Hiltrud, Brinton, Louise, Broberg, Per, Brucker, Sara Y., Burwinkel, Barbara, Caldés, Trinidad, Canzian, Federico, Christiansen, Hans, Collée, Margriet, Cornelissen, Sten, Couch, Fergus J., Cox, David, Cross, Simon S., Cunningham, Julie M., Dörk, Thilo, dos-Santos-Silva, Isabel, Eccles, Diana M., Engel, Christoph, Eriksson, Mikael, Fachal, Laura, Figueroa, Jonine, Flesch-Janys, Dieter, Fletcher, Olivia, Gabrielson, Marike, Gaudet, Mia M., Giles, Graham G., Goldberg, Mark S., González-Neira, Anna, Guénel, Pascal, Håkansson, Niclas, Hall, Per, Hamann, Ute, Harrington, Patricia, Hein, Alexander, Hicks, Belynda, Hoover, Robert N., Huang, Guanmengqian, Humphreys, Keith, Hunter, David J., Jakubowska, Anna, John, Esther M., Jones, Kristine, Jones, Michael E., Jung, Audrey, Khusnutdinova, Elza, Kristensen, Vessela N., Lambrechts, Diether, Le Marchand, Loic, Li, Jingmei, Lo, Wing-Yee, Loibl, Sibylle, Lubinski, Jan, Luccarini, Craig, Lux, Michael P., Meindl, Alfons, Nevanlinna, Heli, Olopade, Olufunmilayo I., Peterlongo, Paolo, Peto, Julian, Presneau, Nadege, Rennert, Gad, Romero, Atocha, Romm, Jane, Rudolph, Anja, Saloustros, Emmanouil, Sandler, Dale P., Schmidt, Marjanka K., Scott, Rodney J., Scott, Christopher G., Seal, Sheila, Surowy, Harald, Tamimi, Rulla M., Tapper, William, Tessier, Daniel C., Tollenaar, Rob A. E. M., Torres, Diana, Truong, Thérèse, Van Den Berg, David, Vincent, Daniel, Whittemore, Alice S., Wildiers, Hans, Willett, Walter C., Wolk, Alicja, Ziogas, Argyrios, Dunning, Alison M., Simard, Jacques, Easton, Douglas F., Zheng, Wei

“…The breast cancer risk variants identified in genome-wide association studies explain only a small fraction of the familial relative risk, and the genes…”
Get full text

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis by Shu, Xiang, Wu, Lang, Khankari, Nikhil K, Shu, Xiao-Ou, Wang, Thomas J, Michailidou, Kyriaki, Bolla, Manjeet K, Wang, Qin, Dennis, Joe, Milne, Roger L, Schmidt, Marjanka K, Pharoah, Paul D P, Andrulis, Irene L, Hunter, David J, Simard, Jacques, Easton, Douglas F, Zheng, Wei

“…Abstract Background In addition to the established association between general obesity and breast cancer risk, central obesity and circulating fasting insulin…”
Get full text

Genome-wide association analysis identifies three new breast cancer susceptibility loci by Fletcher, Olivia, Turnbull, Clare, Dicks, Ed, Dennis, Joe, Luccarini, Craig, Baynes, Caroline, Driver, Kristy, Orr, Nicholas, dos Santos Silva, Isabel, Uitterlinden, Andre G, Rivadeneira, Fernando, Hall, Per, Czene, Kamila, Aittomäki, Kristiina, Meindl, Alfons, Lichtner, Peter, Nickels, Stefan, Flesch-Janys, Dieter, Tsimiklis, Helen, Schmidt, Daniel, Bui, Minh, Apicella, Carmel, Park, Daniel J, Chanock, Stephen J, Verhoef, Senno, Hogervorst, Frans B L, Fasching, Peter A, Beckmann, Matthias W, Ekici, Arif B, Tomlinson, Ian, Kerin, Michael, Sohn, Christof, Burwinkel, Barbara, Guénel, Pascal, Truong, Thérèse, Menegaux, Florence, Nordestgaard, Børge G, Flyger, Henrik, Milne, Roger L, Alonso, M Rosario, Benítez, Javier, Anton-Culver, Hoda, Ziogas, Argyrios, Brenner, Hermann, Stegmaier, Christa, Brauch, Hiltrud, Brüning, Thomas, Eilber, Ursula, Bremer, Michael, Hillemanns, Peter, Antonenkova, Natalia N, Rogov, Yuri I, Karstens, Johann H, Bermisheva, Marina, Khusnutdinova, Elza, Lindblom, Annika, Margolin, Sara, Mannermaa, Arto, Hartikainen, Jaana M, Floris, Giuseppe, Fortuzzi, Stefano, Peterlongo, Paolo, Couch, Fergus J, Stevens, Kristen, Giles, Graham G, Baglietto, Laura, Severi, Gianluca, Alnæs, Grethe Grenaker, Kristensen, Vessela, Børrensen-Dale, Anne-Lise, John, Esther M, Miron, Alexander, Andrulis, Irene L, Devilee, Peter, Seynaeve, Caroline, Figueroa, Jonine D, Garcia-Closas, Montserrat, Brinton, Louise, Hooning, Maartje J, van den Ouweland, Ans M W, Reed, Malcolm W R, Shah, Mitul, Jakubowska, Ania, Lubinski, Jan, Durda, Katarzyna, Jones, Michael, Schoemaker, Minouk, Swerdlow, Anthony, Beesley, Jonathan, Chen, Xiaoqing, Lophatananon, Artitaya, Rattanamongkongul, Suthee, Noh, Dong-Young, Velentzis, Louiza, Tapper, Will J, Gerty, Susan M, Graham, Nikki J, Ponder, Bruce A J, Dunning, Alison M, Peto, Julian

“…Douglas Easton and colleagues report a genome-wide association analyses for breast cancer in ~70,000 cases and ~68,000 controls. They identify three new breast…”
Get full text

Genome-wide association study of germline variants and breast cancer-specific mortality by Canisius, Sander, Beesley, Jonathan, Lecarpentier, Julie, Anton-Culver, Hoda, Bermisheva, Marina, Bernstein, Leslie, Blomqvist, Carl, Bonanni, Bernardo, Børresen-Dale, Anne-Lise, Brucker, Sara Y., Burwinkel, Barbara, Campa, Daniele, Carter, Brian D., Chang-Claude, Jenny, Chenevix-Trench, Georgia, Cheng, Ting-Yuan David, Clarke, Christine L., Cordina-Duverger, Emilie, Couch, Fergus J., Dunn, Janet A., Dunning, Alison M., Durcan, Lorraine, Eliassen, A. Heather, Ellberg, Carolina, Eriksson, Mikael, Gabrielson, Marike, Galle, Eva, Gapstur, Susan M., García-Closas, Montserrat, García-Sáenz, José A., Gaudet, Mia M., Giles, Graham G., Goldgar, David E., Guénel, Pascal, Haeberle, Lothar, Hahnen, Eric, Haiman, Christopher A., Hankinson, Susan, Hart, Steven N., Hillemanns, Peter, Holleczek, Bernd, Hooning, Maartje J., Hopper, John L., Huang, Guanmengqian, Humphreys, Keith, Hunter, David J., John, Esther M., Jones, Michael E., Kabisch, Maria, Kaczmarek, Katarzyna, Kiiski, Johanna I., Knight, Julia A., Ko, Yon-Dschun, Kosma, Veli-Matti, Kristensen, Vessela N., Lee, Eunjung, Li, Lian, Lindblom, Annika, Lindström, Sara, Lo, Wing-Yee, Lux, Michael P., MacInnis, Robert J., Makalic, Enes, Mannermaa, Arto, Manoochehri, Mehdi, Manoukian, Siranoush, Margolin, Sara, Martinez, Maria Elena, Mavroudis, Dimitrios, Meindl, Alfons, Middha, Pooja, Mulligan, Anna Marie, Nassir, Rami, Nielsen, Sune F., Orr, Nick, Pankratz, V. Shane, Perez, Jose I. A., Pinchev, Mila, Pylkäs, Katri, Rack, Brigitte, Rennert, Hedy S., Saloustros, Emmanouil, Sawyer, Elinor J., Schmutzler, Rita K., Schumacher, Fredrick, Shah, Mitul, Simard, Jacques, Smeets, Ann, Tamimi, Rulla M., Teixeira, Manuel R., Turnbull, Clare, van Asperen, Christi J., van den Ouweland, Ans M. W., Whittemore, Alice S., Yang, Xiaohong R., Zhang, Yan, Easton, Douglas F., Fasching, Peter A., Pharoah, Paul D. P., Schmidt, Marjanka K.

“…Background We examined the associations between germline variants and breast cancer mortality using a large meta-analysis of women of European ancestry…”
Get full text

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer by Purrington, Kristen S., Eccles, Diana, Yannoukakos, Drakoulis, Fasching, Peter A., Miron, Penelope, Carpenter, Jane, Chang-Claude, Jenny, Martin, Nicholas G., Montgomery, Grant W., Kristensen, Vessela, Anton-Culver, Hoda, Goodfellow, Paul, Tapper, William J., Rafiq, Sajjad, Gerty, Susan M., Durcan, Lorraine, Konstantopoulou, Irene, Fostira, Florentia, Vratimos, Athanassios, Konstanta, Irene, Kotoula, Vassiliki, Lakis, Sotiris, Dimopoulos, Meletios A., Skarlos, Dimosthenis, Pectasides, Dimitrios, Fountzilas, George, Beckmann, Matthias W., Hein, Alexander, Ruebner, Matthias, Ekici, Arif B., Hartmann, Arndt, Schulz-Wendtland, Ruediger, Renner, Stefan P., Janni, Wolfgang, Rack, Brigitte, Scholz, Christoph, Neugebauer, Julia, Andergassen, Ulrich, Lux, Michael P., Haeberle, Lothar, Clarke, Christine, Pathmanathan, Nirmala, Rudolph, Anja, Flesch-Janys, Dieter, Nickels, Stefan, Olson, Janet E., Ingle, James N., Olswold, Curtis, Slettedahl, Seth, Eckel-Passow, Jeanette E., Anderson, S.Keith, Visscher, Daniel W., Cafourek, Victoria L., Sicotte, Hugues, Prodduturi, Naresh, Weiderpass, Elisabete, Bernstein, Leslie, Ziogas, Argyrios, Giles, Graham G., Baglietto, Laura, Kosma, Veli-Matti, Fischer, Hans-Peter, Reed, Malcom W.R., Cross, Simon S., Deming-Halverson, Sandra, Shrubsole, Martha, Cai, Qiuyin, Shu, Xiao-Ou, Daly, Mary, Weaver, JoEllen, Ross, Eric, Klemp, Jennifer, Sharma, Priyanka, Rüdiger, Thomas, Ulmer, Hans-Ulrich, Försti, Asta, Khoury, Thaer, Kumar, Shicha, Pilarski, Robert, Shapiro, Charles L., Greco, Dario, Heikkilä, Päivi, Aittomäki, Kristiina, Blomqvist, Carl, Irwanto, Astrid, Liu, Jianjun, Pankratz, Vernon Shane, Wang, Xianshu, Severi, Gianluca, Easton, Douglas, Hall, Per, Brauch, Hiltrud, Cox, Angela, Godwin, Andrew K., Hamann, Ute, Ambrosone, Christine, Toland, Amanda Ewart, Nevanlinna, Heli, Vachon, Celine M., Couch, Fergus J.

“…Summary In a genome-wide scan, we show that 30 variants in 25 genomic regions are associated with risk of TN breast cancer. Women carrying many of the risk…”
Get full text

MELODY (Methods for Localization of Different Types of Breast Lesions): A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET) by Banys-Paluchowski, Maggie, Kühn, Thorsten, Masannat, Yazan, Rubio, Isabel T., de Boniface, Jana, Ditsch, Nina, Karakatsanis, Andreas, Dave, Rajiv V, Potter, Shelley, Kothari, Ashutosh, Gentilini, Oreste Davide, Weber, Walter Paul, Krawczyk, Natalia, Hartmann, Steffi, Karadeniz Cakmak, Guldeniz, Hahn, Markus, Lux, Michael Patrick, Smidt, Marjolein, Cabioglu, Neslihan, Harvey, James

“…TPS626 Background: In the last decades, the proportion of breast cancer patients receiving breast-conserving surgery has increased, reaching 70-80% in…”
Get full text

Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411) by Banys-Paluchowski, Maggie, Kühn, Thorsten, Masannat, Yazan, Rubio, Isabel, de Boniface, Jana, Ditsch, Nina, Karadeniz Cakmak, Güldeniz, Karakatsanis, Andreas, Dave, Rajiv, Hahn, Markus, Potter, Shelley, Kothari, Ashutosh, Gentilini, Oreste Davide, Gulluoglu, Bahadir M, Lux, Michael Patrick, Smidt, Marjolein, Weber, Walter Paul, Aktas Sezen, Bilge, Krawczyk, Natalia, Hartmann, Steffi, Di Micco, Rosa, Nietz, Sarah, Malherbe, Francois, Cabioglu, Neslihan, Canturk, Nuh Zafer, Gasparri, Maria Luisa, Murawa, Dawid, Harvey, James

“…Surgical excision of a non-palpable breast lesion requires a localization step. Among available techniques, wire-guided localization (WGL) is most commonly…”
Get full text

Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1 by Michailidou, Kyriaki, Edwards, Stacey L., Prathalingham, Radhika, Dennis, Joe, de Santiago, Ines, Hopper, John L., Van ’t Veer, Laura J., Hogervorst, Frans B., Muir, Kenneth, Lophatananon, Artitaya, Fasching, Peter A., Lux, Michael P., Peto, Julian, dos Santos Silva, Isabel, Johnson, Nichola, Miller, Nicola, Marme, Federick, Burwinkel, Barbara, Guénel, Pascal, Truong, Thérèse, Menegaux, Florence, Bojesen, Stig E., Nordestgaard, Børge G., Flyger, Henrik, Zamora, M. Pilar, Benitez, Javier, Ziogas, Argyrios, Brenner, Hermann, Müller, Heiko, Arndt, Volker, Schmutzler, Rita K., Engel, Christoph, Brauch, Hiltrud, Brüning, Thomas, Ko, Yon-Dschun, Muranen, Taru A., Blomqvist, Carl, Matsuo, Keitaro, Dörk, Thilo, Helbig, Sonja, Bogdanova, Natalia V., Lindblom, Annika, Mannermaa, Arto, Wu, Anna H., Stram, Daniel O., Thienpont, Bernard, Christiaens, Marie-Rose, Flesch-Janys, Dieter, Radice, Paolo, Peterlongo, Paolo, Bernard, Loris, Wang, Xianshu, Purrington, Kristen, Severi, Gianluca, Baglietto, Laura, McLean, Catriona, Henderson, Brian E., Simard, Jacques, Goldberg, Mark S., Labrèche, France, Yip, Cheng-Har, Phuah, Sze-Yee, Grenaker Alnæs, Grethe, Børresen-Dale, Anne-Lise, Pylkäs, Katri, Kauppila, Saila, Knight, Julia A., Devilee, Peter, Seynaeve, Caroline M., García-Closas, Montserrat, Figueroa, Jonine, Czene, Kamila, Darabi, Hartef, Hooning, Maartje J., Martens, John W.M., van den Ouweland, Ans M.W., Li, Jingmei, Shu, Xiao-Ou, Lu, Wei, Gao, Yu-Tang, Cai, Hui, Reed, Malcolm W.R., Signorello, Lisa B., Pharoah, Paul D.P., Ghoussaini, Maya, Choi, Ji-Yeob, Noh, Dong-Young, Hui, Miao, Ulmer, Hans-Ulrich, Jakubowska, Anna, Lubinski, Jan, Durda, Katarzyna, McKay, James, Slager, Susan, Shen, Chen-Yang, Hou, Ming-Feng, Swerdlow, Anthony, Ashworth, Alan, Schoemaker, Minouk J., Dunning, Alison M.

“…The 10q26 locus in the second intron of FGFR2 is the locus most strongly associated with estrogen-receptor-positive breast cancer in genome-wide association…”
Get full text

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This? by Lux, Michael Patrick, Ciani, Oriana, Dunlop, William C N, Ferris, Andrea, Friedlander, Michael

“…Mature overall survival (OS) data are often unavailable at the time of regulatory and reimbursement decisions for a new cancer treatment. For patients with…”
Get full text

Abstract P2-09-04: Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+ breast cancer by Reimann, H, Nguyen, A, Hübner, H, Erber, R, Bausenwein, J, Van der Meijden, ED, Lux, MP, Jud, S, Griffioen, M, Rauh, C, Sanborn, JZ, Benz, SC, Rabizadeh, S, Beckmann, MW, Mackensen, A, Rübner, M, Fasching, PA, Kremer, AN

“…Abstract Background: Recent studies have demonstrated that the number of tumor infiltrating lymphocytes (TILs) positively correlates with outcome and response…”
Get full text

Hereditary breast and ovarian cancer : review and future perspectives by LUX, Michael P, FASCHING, Peter A, BECKMANN, Matthias W

“…Breast cancer (BC) is the most frequent carcinoma in women. The cumulative risk for the disease is 10% up to the age of 80 years. A familial history of BC and…”
Get full text

Abstract OT1-11-02: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/ metastatic setting (NCT02338167) by Müller, V, Huober, J, Volz, B, Overkamp, F, Kolberg, H-C, Hadji, P, Haeberle, L, Ettl, J, Hartkopf, AD, Lux, MP, Lüftner, DI, Wallwiener, M, Taran, F-A, Beckmann, MW, Belleville, E, Wimberger, P, Hielscher, C, Geberth, M, Lermann, J, Abenhardt, A, Kurbacher, C, Wuerstlein, R, Thomssen, C, Untch, M, Janni, W, Fehm, TN, Brucker, SY, Wallwiener, D, Schneeweiss, A, Fasching, PA, Tesch, H

“…Abstract Background During the last decades the treatment of advanced breast cancer (ABC) patients has improved due to a variety of new treatment strategies…”
Get full text

Abstract P6-17-22: Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167) by Schneeweiss, A, Lux, MP, Hartkopf, AD, Volz, B, Kolberg, H-C, Hadji, P, Tesch, H, Haeberle, L, Ettl, J, Lüftner, DI, Wallwiener, M, Müller, V, Beckmann, MW, Belleville, E, Wimberger, P, Hielscher, C, Geberth, M, Lermann, J, Abenhardt, W, Kurbacher, C, Wuerstlein, R, Thomssen, C, Untch, M, Overkamp, F, Huober, J, Taran, F-A, Janni, W, Wallwiener, D, Brucker, SY, Fasching, PA, Fehm, TN

“…Abstract Background Studies leading to the approval of trastuzumab emtansine (T-DM1) have been conducted without pertuzumab as previous therapy. Therefore data…”
Get full text

Abstract P6-17-37: Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167) by Lux, MP, Hartkopf, AD, Huober, J, Volz, B, Taran, F-A, Overkamp, F, Hadji, P, Tesch, H, Haeberle, L, Ettl, J, Lueftner, DI, Wallwiener, M, Müller, V, Beckmann, MW, Belleville, E, Wimberger, P, Hielscher, C, Geberth, M, Lermann, J, Abenhardt, W, Kurbacher, C, Wuerstlein, R, Thomssen, C, Untch, M, Fasching, PA, Janni, W, Fehm, TN, Wallwiener, D, Brucker, SY, Schneeweiss, A, Kolberg, H-C

“…Abstract Purpose: This analysis describes comprehensive real-world data concerning the use of anti-HER2 therapies in HER2 positive metastatic breast cancer…”
Get full text

Abstract P6-11-10: Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry by Wallwiener, M, Nabieva, N, Haeberle, L, Taran, FA, Hartkopf, AD, Volz, B, Overkamp, F, Brandl, AL, Kolberg, H-C, Hadji, P, Tesch, H, Ettl, J, Lux, MP, Lueftner, D, Belleville, E, Fasching, PA, Janni, W, Beckmann, MW, Wimberger, P, Hielscher, C, Fehm, T, Brucker, SY, Wallwiener, D, Schneeweiss, A, Mueller, V

“…Abstract Background: Improved progression-free survival is considered as treatment goal for patients with metastatic breast cancer (MBC) since it is assumed to…”
Get full text

Abstract P1-07-20: Developing prognostic indicators of poor outcomes in PRAEGNANT metastatic breast cancer cohort by Szeto, C, Benz, S, Nguyen, A, Rübner, M, Wallwiener, D, Tesch, H, Hadji, P, Fehm, TN, Janni, W, Overkamp, F, Lueftner, D, Lux, MP, Wallwiener, M, Beckmann, MW, Huebner, H, Ettl, J, Hartkopf, AD, Mueller, V, Taran, FA, Belleville, E, Schneeweiss, A, Soon-Shiong, P, Rabizadeh, S, Fasching, PA

“…Abstract Background: Despite novel, targeted therapies, metastatic breast cancer patients have an extremely unfavourable prognosis. Prognostic and predictive…”
Get full text

Abstract PD1-02: Cancer predisposition genes in metastatic breast cancer – Association with metastatic pattern, prognosis, patient and tumor characteristics by Fasching, PA, Hu, C, Hart, SN, Polley, EC, Lee, KY, Gnanolivu, RD, Lilyquist, J, Hartkopf, AD, Taran, FA, Janni, W, Hadji, P, Tesch, H, Haeberle, L, Ettl, J, Lux, MP, Lueftner, D, Wallwiener, M, Mueller, V, Beckmann, MW, Belleville, E, Wimberger, P, Untch, M, Kolberg, H-C, Fehm, TN, Overkamp, F, Wallwiener, D, Brucker, SY, Schneeweiss, A, Couch, F

“…Abstract Background New treatment strategies for metastatic breast cancer (mBC) are mainly driven by therapies against specific targets. BRCA mutations are one…”
Get full text

Abstract P3-11-07: Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry by Huober, J, Fasching, PA, Taran, F-A, Volz, B, Overkamp, F, Kolberg, HC, Hadji, P, Tesch, H, Haeberle, L, Ettl, J, Hartkopf, AD, Lux, MP, Lueftner, D, Wallwiener, M, Mueller, V, Beckmann, MW, Belleville, E, Wimberger, P, Hielscher, C, Geberth, M, Fersis, N, Abenhardt, W, Kurbacher, C, Wuerstlein, R, Thomssen, C, Untch, M, Janni, W, Wallwiener, D, Brucker, SY, Schneeweiss, A, Fehm, TN

“…Abstract Background For breast cancer patients with metastases which are not life threatening national and international guidelines recommend the exhaustion of…”
Get full text

Abstract P5-21-09: Overall survival of metastatic breast cancer patients – data from the PRAEGNANT breast cancer registry by Taran, F-A, Fasching, PA, Volz, B, Huober, J, Overkamp, F, Kolberg, HC, Hadji, P, Tesch, H, Haeberle, L, Ettl, J, Lux, MP, Hartkopf, AD, Lueftner, D, Wallwiener, M, Müller, V, Beckmann, MW, Belleville, E, Wimberger, P, Hielscher, C, Geberth, M, Fersis, N, Abenhardt, W, Kurbacher, C, Wuerstlein, R, Thomssen, C, Untch, M, Janni, W, Fehm, TN, Wallwiener, D, Brucker, SY, Schneeweiss, A

“…Abstract Background Breast Cancer registries can help to understand how patient groups are treated outside clinical trials and what outcome is to expected for…”
Get full text

Abstract OT3-02-09: Seraphina – Safety efficacy and patient reported outcomes of advanced breast cancer patients: Therapy management with NAB-paclitaxel in daily routine by Fasching, PA, Wallwiener, M, Lux, MP, Mueller, V, Schneeweiss, A, Tesch, H, Brucker, SY, Haeberle, L, Spall, T, Belleville, E, Lück, H-J

“…Abstract BACKGROUND Treatment of patients with advanced breast cancer (ABC) has evolved significantly. Nevertheless, further improvement in ABC treatment is a…”
Get full text